Zhang Na, Sun Ning, Wang Li-Qiong, Zou Xuan, Yang Jing-Wen, Shi Guang-Xia, Liu Cun-Zhi
Acupuncture-Moxibustion Research Center, Beijing University of CM, Beijing 100029, China; College of Acupuncture-Moxibustion and Tuina, Shandong University of TCM, Jinan 250355.
Acupuncture-Moxibustion Research Center, Beijing University of CM, Beijing 100029, China; College of Acupuncture- Moxibustion and Tuina, Beijing University of CM, Beijing 100029.
Zhongguo Zhen Jiu. 2020 Aug 12;40(8):902-6. doi: 10.13703/j.0255-2930.20190620-k0003.
To evaluate the reporting quality of randomized controlled trials (RCTs) of acupuncture for vascular dementia.
The RCTs of acupuncture for vascular dementia were systematically retrieved from the Cochrane Library, PubMed, EMbase, CNKI, SinoMed, VIP and Wanfang databases from the date of establishment to October 31, 2018. The reporting quality of RCT was evaluated based on the internationally-recognized Consolidated Standards for Reporting of Trials (CONSORT) statement and Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA).
A total of 33 RCTs were included. According to the CONSORT statement, 12 items had a reporting rate of 0%, including important changes to methods after trial commencement, sample size, blind method, trial registry, etc.; 5 items had a reporting rate of below 10%, including trial design, type of randomization, random allocation sequence, randomization implementation and participant flow. The reporting rate was 36.36% for baseline data and 57.58% for randomization sequence generation. According to the STRICTA statement, the reporting rate was 21.21% for description of acupuncture depth, 60.61% for description of acupuncture response, 27.27% for description of additional intervention details and 0% for qualification of acupuncturists, respectively.
At present, the reporting quality of RCTs of acupuncture for vascular dementia is generally low. In the future, the RCTs of acupuncture for vascular dementia should be normatively reported according to the CONSORT statement and STRICTA statement.
评估针刺治疗血管性痴呆随机对照试验（RCT）的报告质量。
从Cochrane图书馆、PubMed、EMbase、中国知网、中国生物医学文献数据库、维普资讯和万方数据库中系统检索自建库至2018年10月31日针刺治疗血管性痴呆的RCT。根据国际认可的《试验报告统一标准》（CONSORT）声明和《针刺对照试验干预措施报告标准》（STRICTA）评估RCT的报告质量。
共纳入33项RCT。根据CONSORT声明，12项的报告率为0%，包括试验开始后方法的重要变更、样本量、盲法、试验注册等；5项的报告率低于10%，包括试验设计、随机化类型、随机分配序列、随机化实施和受试者流程。基线数据的报告率为36.36%，随机分配序列产生的报告率为57.58%。根据STRICTA声明，针刺深度描述的报告率为21.21%，针刺反应描述的报告率为60.61%，额外干预细节描述的报告率为27.27%，针灸师资质的报告率为0%。
目前，针刺治疗血管性痴呆RCT的报告质量普遍较低。未来，针刺治疗血管性痴呆的RCT应按照CONSORT声明和STRICTA声明进行规范报告。
